VANCOUVER, BRITISH COLUMBIA - (Marketwire - Jan. 6, 2009) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) ("the Company" or "ALDA") announces that a new DIN (02321424) has been issued by Health Canada for T36(R) Antiseptic Hand Sanitizer in liquid form. This new product complements ALDA's previously approved T36(R) Antiseptic Hand Sanitizer Gel and allows the formulation to be manufactured and sold as a spray.
Compared to typical alcohol-based hand sanitizers, ALDA's T36(R) Antiseptic Hand Sanitizer is a unique formula with two active ingredients that provide faster action against a broader range of infectious organisms and offer a long-lasting residual effect.
About ALDA Pharmaceuticals
ALDA is focused on the development of infection-control therapeutics derived from its patented T36(R) technology. The company trades on the TSX Venture Exchange under the symbol APH.
Terrance G. Owen, Ph.D., MBA, President & CEO
ALDA Pharmaceuticals Corp.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Website: www.aldacorp.com
Tags: ,Pharmaceuticals and Biotech,Equipment and Supplies,NEW PRODUCTS/SERVICES
_ _Is your favorite bookmark site missing?
Ask for it.
Search News
Daily News
